Low dose and dose escalating therapy of interferon alfa-2a in the treatment of refractory and sight-threatening Behcet's uveitis

被引：0
|
作者：
Onal, S. [1 ]
Kazokoglu, H. [1 ]
Koc, A. [1 ]
Akman, M. [2 ]
Bavbek, T. [1 ]
Direskeneli, H. [3 ]
Yavuz, S. [3 ]
机构：
[1] Marmara Univ, Sch Med, Dept Ophthalmol, Uveitis Serv, Istanbul, Turkey
[2] Marmara Univ, Sch Med, Dept Family Med, Istanbul, Turkey
[3] Marmara Univ, Dept Internal Med, Div Rheumatol, Istanbul, Turkey
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2009年 / 27卷 / 02期
关键词：
DISEASE; EFFICACY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [1] LONG-TERM EFFICACY AND SAFETY OF LOW DOSE AND DOSE ESCALATING INTERFERON ALFA-2A THERAPY IN REFRACTORY BEHCET'S UVEITIS
    Onal, Sumru
    Kazokoglu, Haluk
    Koc, Aylin
    Akman, Mehmet
    Bavbek, Tayfun
    Direskenell, Haner
    Yavuz, Sule
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S147 - S147
  • [2] Long-term Efficacy and Safety of Low-Dose and Dose-Escalating Interferon Alfa-2a Therapy in Refractory Behcet Uveitis
    Onal, Sumru
    Kazokoglu, Haluk
    Koc, Aylin
    Akman, Mehmet
    Bavbek, Tayfun
    Direskeneli, Haner
    Yavuz, Sule
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (03) : 288 - 294
  • [3] Low-dose Interferon Alfa-2a Therapy in Severe Uveitis Associated with Behcet Disease
    Onal, Sumru
    Kazokoglu, Haluk
    Direskeneli, Haner
    Yavuz, Sule
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 147 (06) : 1109 - 1110
  • [4] Infliximab For Sight-Threatening and Refractory Uveitis Of Behcet's Syndrome
    Hamuryudan, Vedat
    Hatemi, Gulen
    Ozyazgan, Yilmaz
    Ucar, Didar
    Yurdakul, Sebahattin
    Seyahi, Emire
    Tascilar, Koray
    Ugurlu, Serdal
    Yazici, Hasan
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S1119 - S1119
  • [5] INFLIXIMAB FOR SIGHT-THREATENING AND REFRACTORY UVEITIS OF BEHCET'S SYNDROME
    Hamuryudan, V.
    Hatemi, G.
    Ozyazgan, Y.
    Ucar, D.
    Yurdakul, S.
    Seyahi, E.
    Tascilar, K.
    Ugurlu, S.
    Yazici, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 488 - 488
  • [6] Low-dose Interferon Alfa-2a Therapy in Severe Uveitis Associated with Behcet Disease REPLY
    Gueudry, Julie
    Terrada, Celine
    Wechsler, Bertrand
    Cassoux, Nathalie
    Huong, Du Le Thi
    Fardeau, Christine
    Lehoang, Phuc
    Piette, Jean-Charles
    Bodaghi, Bahram
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 147 (06) : 1110 - 1110
  • [7] Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behcet's Disease
    Park, Ji-Youn
    Chung, Yoo-Ri
    Lee, Kihwang
    Song, Ji Hun
    Lee, Eun-So
    [J]. YONSEI MEDICAL JOURNAL, 2015, 56 (04) : 1158 - 1162
  • [8] Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis
    Kötter, I
    Zierhut, M
    Eckstein, AK
    Vonthein, R
    Ness, T
    Günaydin, I
    Grimbacher, B
    Blaschke, S
    Meyer-Riemann, W
    Peter, HH
    Stübiger, N
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (04) : 423 - 431
  • [9] Adalimumab for sight-threatening uveitis in Behcet's disease
    Mushtaq, B.
    Saeed, T.
    Situnayake, R. D.
    Murray, P. I.
    [J]. EYE, 2007, 21 (06) : 824 - 825
  • [10] EFFICACY OF INFLIXIMAB IN THE TREATMENT OF SIGHT-THREATENING UVEITIS IN BEHCET'S DISEASE
    Ajili, F.
    Bellakhal, S.
    Metoui, L.
    Sayhi, S.
    Boussetta, N.
    Laabidi, J.
    Louzir, B.
    Ben Abdelhafidh, N.
    Othmani, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 493 - 493
12345